Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chong-Jen Yu

Showing results (81-90 of 478) with videos related to

Pageof 48
Sort By:
Respiratory Care|July 12, 2012
Asynchronous thoraco-abdominal motion contributes to decreased 6-minute walk test in patients with COPDJung-Yien Chien, Sheng-Yuan Ruan, Yuh-Chin T Huang, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2004
Sialyl Lewis antigens: association with MUC5AC protein and correlation with post-operative recurrence of non-small cell lung cancerChong-Jen Yu, Jin-Yuan Shih, Yung-Chie Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancerAng Yuan, Chong-Jen Yu, Kwen-Tay Luh, et al.
Plos One|December 10, 2014
In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based studyTe-Wei Ho, Yi-Ju Tsai, Sheng-Yuan Ruan, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 23, 2018
Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPDChih-Cheng Lai, Ya-Hui Wang, Cheng-Yi Wang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 30, 2005
Gefitinib treatment for non-small cell lung cancer -- a study including patients with poor performance statusWen-Pin Su, Chih-Hsin Yang, Chong-Jen Yu, et al.
Plos One|April 15, 2017
Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortalityTe-Wei Ho, Chun-Ta Huang, Sheng-Yuan Ruan, et al.
Critical Care Medicine|October 11, 2018
Risk of Sepsis and Mortality Among Patients With Chronic Obstructive Pulmonary Disease Treated With Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor BlockersChih-Cheng Lai, Ya-Hui Wang, Cheng-Yi Wang, et al.
Journal of Clinical Medicine|August 24, 2018
Risks of Pneumonia in COPD Patients with New-Onset Atrial FibrillationYa-Hui Wang, Chih-Cheng Lai, Cheng-Yi Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|April 15, 2005
Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trialsSung-Hsin Kuo, Chih-Hsin Yang, Chong-Jen Yu, et al.
Pageof 48

Showing results (81-90 of 478) with videos related to

Sort By:
Pageof 48
Respiratory Care|July 12, 2012
Asynchronous thoraco-abdominal motion contributes to decreased 6-minute walk test in patients with COPDJung-Yien Chien, Sheng-Yuan Ruan, Yuh-Chin T Huang, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2004
Sialyl Lewis antigens: association with MUC5AC protein and correlation with post-operative recurrence of non-small cell lung cancerChong-Jen Yu, Jin-Yuan Shih, Yung-Chie Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancerAng Yuan, Chong-Jen Yu, Kwen-Tay Luh, et al.
Plos One|December 10, 2014
In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based studyTe-Wei Ho, Yi-Ju Tsai, Sheng-Yuan Ruan, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 23, 2018
Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPDChih-Cheng Lai, Ya-Hui Wang, Cheng-Yi Wang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 30, 2005
Gefitinib treatment for non-small cell lung cancer -- a study including patients with poor performance statusWen-Pin Su, Chih-Hsin Yang, Chong-Jen Yu, et al.
Plos One|April 15, 2017
Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortalityTe-Wei Ho, Chun-Ta Huang, Sheng-Yuan Ruan, et al.
Critical Care Medicine|October 11, 2018
Risk of Sepsis and Mortality Among Patients With Chronic Obstructive Pulmonary Disease Treated With Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor BlockersChih-Cheng Lai, Ya-Hui Wang, Cheng-Yi Wang, et al.
Journal of Clinical Medicine|August 24, 2018
Risks of Pneumonia in COPD Patients with New-Onset Atrial FibrillationYa-Hui Wang, Chih-Cheng Lai, Cheng-Yi Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|April 15, 2005
Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trialsSung-Hsin Kuo, Chih-Hsin Yang, Chong-Jen Yu, et al.
Pageof 48